Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
S01BA07	OPTILONE	G	Fluorometholone - 0.1%	0.1%	Solution	309,084 L.L
A02BC01	RISEK	G	Omeprazole (sodium) - 40mg	40mg	Injectable lyophilised powder for solution	592,635 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	186,167 L.L
C05AA01	SINAHEAL-H	G	Hydrocortisone acetate - 5mg, Lidocaine - 60mg, Zinc oxide - 400mg, Aluminium Subacetate - 50mg		Suppository	501,253 L.L
C09CA04	IRBESARTAN ARROW	G	Irbesartan - 300mg	300mg	Tablet	470,345 L.L
C10AA07	ROSUCOR	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	487,623 L.L
G04CA01	ALFOCIN	G	Alfuzosin HCl - 10mg	10mg	Tablet, extended release	858,779 L.L
J01MA14	FLOXIMOX	G	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	1,062,276 L.L
M01AH05	CLINTON	G	Etoricoxib - 120mg	120mg	Tablet, film coated	362,837 L.L
N02BE01	PARAMOL	G	Paracetamol - 120mg/5ml	120mg/5ml	Syrup, alcohol free	85,750 L.L
R03BA02	BUDECORT	G	Budesonide - 1mg	1mg	Respule	1,226,928 L.L
A02BC01	ULCAZAL	G	Omeprazole (sodium) - 40mg	40mg	Injectable sterile lyophilised powder for solution	895,895 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	205,703 L.L
C05AA01	SINAHEAL-H	G	Hydrocortisone acetate - 0.275g/100g, Lidocaine - 5g/100g, Zinc oxide - 18g/100g, Aluminium Subacetate - 3.5g/100g		Ointment	330,585 L.L
C09CA04	IRTAN	G	Irbesartan - 300mg	300mg	Tablet	554,175 L.L
C10AA07	ROSUPHAR	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	487,623 L.L
G04CA01	ALFUZOSINE BIOGARAN LP	G	Alfuzosin HCl - 10mg	10mg	Tablet, coated, prolonged release	1,115,389 L.L
J01MA14	LOXIMED	G	Moxifloxacin (HCl) - 400mg	400mg	Tablet	851,100 L.L
L01AX03	TEGOZOL	G	Temozolomide - 250mg	250mg	Capsule	24,856,894 L.L
M01AH05	CONSORT	G	Etoricoxib - 120mg	120mg	Tablet, film coated	309,084 L.L
N02BE01	PAROL INFANTS	G	Paracetamol - 120mg/5ml	120mg/5ml	Syrup	281,567 L.L
N05AH02	CLOZAPINE PANPHARMA	G	Clozapine - 100mg	100mg	Tablet, scored	808,993 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 0.5mg/2ml	0.5mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
L01EF01	PAPILLIO	G	Palbociclib - 100mg	100mg	Capsule, hard	L.L
A02BC01	ULCAZAL	G	Omeprazole (sodium) - 40mg	40mg	Injectable sterile lyophilised powder for solution	5,916,747 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	221,792 L.L
C05AE01	RECTOGESIC	G	Glyceryl trinitrate - 0.2% w/w	0.2% w/w	Ointment	2,553,301 L.L
C09CA04	ZIOREL	G	Irbesartan - 300mg	300mg	Tablet, film coated	575,933 L.L
C10AA07	ROSUVAS	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	450,187 L.L
D10AE01	BENZAC AC	G	Benzoyl peroxide - 10g/100g	10%	Gel	416,591 L.L